Stock HOSPIRA, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Hospira, Inc.

Equities

US4410601003

End-of-day quote Nyse
Other stock markets
- USD - Intraday chart for Hospira, Inc.
2015 Hospira : Pfizer wins EU approval for $15 billion Hospira buy RE
2015 Allergan : Mylan independence from Teva's embrace comes with a price RE

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Hospira : Announces First Installation of Plum 360™ Infusion System With Hospira MedNet™
PU
Hospira : Announces First Installation of Plum 360(TM) Infusion System With Hospira MedNet(TM)
PR
Hospira : Expert committee BACKS Hospira’s InflectraTM
PU
Hospira : Charleston Area Medical Center Integrates Smart Pump Technology to Advance Patient Safety
PR
Hospira : TGA Approves First mAb Biosimilar
PR
Hospira : Applauds UK's NICE for Issuing Adoption Resource to Help Drive the Introduction of Biosimilars
PU
Hospira : Pfizer wins EU approval for $15 billion Hospira buy
RE
Allergan : Mylan independence from Teva's embrace comes with a price
RE
Hospira : Announces U.S. Launch of Generic Bivalirudin for Injection
PR
Hospira : to Announce Second-Quarter 2015 Results on July 29, 2015
PR
Hospira : Pfizer offers concessions in bid to win EU okay for Hospira deal
RE
Celltrion : Exclusive - Hospira wins French biosimilar drug tender at 45 percent discount
RE
Hospira : New results from first real-world study show comparable effectiveness and safety of Hospira's Inflectra™ (infliximab) in patients with rheumatic diseases switched from reference infliximab, Remicade™
PU
Hospira : New results from first real-world study show comparable effectiveness and safety of Hospira's Inflectra(TM) (infliximab) in patients with rheumatic diseases switched from reference infliximab, Remicade(TM)
PR
Hospira : ANVISA Approves First Infliximab Biosimilar in Brazil
PU
Hospira : Alliance for Health Reform Bring Food and Drug Administration, Industry Experts Together to Discuss the Future of Biosimilars in the United States
PR
Hospira : Shareholders Approve Merger of Hospira and Pfizer at Special Meeting
PR
Alexion Pharmaceuticals : to bolster rare disease offering with $8.4 billion deal
RE
Hospira : Statement On FDA's Final Biosimilar Guidance Documents
PU
Hospira : Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News Hospira, Inc.